• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jul 7, 2023
Discovery & Translation

Smaller gene editors, Resilience’s cell-free antibody discovery platform and more

BioCentury’s roundup of translational innovations
Read More
BioCentury | Nov 19, 2015
Distillery Therapeutics

Therapeutics: G protein-coupled receptor 183 (GPR183; EBI2)

Read More
BioCentury | May 1, 2014
Distillery Techniques

Technology: Drug platforms

Read More
BioCentury | Aug 18, 2011
Targets & Mechanisms

EBI2: the race is on

Read More
BioCentury | Aug 11, 2011
Distillery Therapeutics

Indication: Autoimmune disease

Read More
BioCentury | Dec 4, 2008
Distillery Therapeutics

Indication: Cancer

Read More
Items per page:
1 - 6 of 6
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa